Analyst Research Report Snapshot

Title:

E. SUN FHC (2884 TT, NT$20.0, N): Downgrade to Neutral

Price:

$58.00

Provider:

KGI Greater China

Date:

28 Oct 2013

Pages:

6

Type:

AcrobatPDF

Companies referenced:

2884.TW

Available for Immediate Download
Summary:

Limited upside; capital raising discussion back on the table 1Q-3Q13 earnings up 16% YoY to NT$6.6bn, in line at 77% of our full-year earnings forecast; 2013F & 2014F earnings growth unchanged at 21% & 10% YoY 10% core revenue growth outlook intact, fee income the bright spot Decent earnings supportive of domestic business growth; but potential overseas expansion brings capital raising discussions back on the table 12M target price raised to NT$21.6 from NT$21, on 1.3x our 2014F BVPS; given limited share upside and uncertainties of capital raising, downgrade to Neutral Shares of E. SUN have outperformed the Taiex and the financial index by a respective 6.9% and 6.4% over the past three months on decent earnings delivery. The stock is currently trading at 1.2x 2014F BVPS, close to the high end of the historical range of 0.7-1.3x. Rolling our valuation base to 2014F BVPS and unchanged target PB of 1.3x, we raise our 12-month target price to NT$21.6 from NT$21, implying 8% upside. We believe E. SUN will continue to deliver robust growth in most earnings drivers on decent market share gains and customer cross-selling. However, given limited share price upside post recent outperformance and uncertainties of capital raising, we downgrade our rating from Outperform to Neutral.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.